Targeting SLC1A5, SLC7A5, SLC38A1, and NUPR1, along with GLS inhibition, disrupts Gln metabolism, increases oxidative stress, and enhances radiosensitivity in PCa. The gene discussed is GLS; the disease is posterior cortical atrophy.